Side Effect Management
Oncology Rehabilitation: An Integral Part of Integrative Care for Head and Neck Cancer Treatment
May 26th 2022Head and neck cancer treatments and the subsequent side effects can be overwhelming for patients and their caregivers due to the impact they have on routine activities, writes a speech-language pathologist at Cancer Treatment Center of America Atlanta. However, the expert notes, there are plenty of specialists who can help improve patient quality of life.
Can a Skin Patch Effectively Control Chemotherapy-Induced Nausea, Vomiting?
April 6th 2022An upcoming phase 2 study will explore if the transdermal (through the skin) delivery of a drug commonly used to treat nausea and vomiting will result in no nausea, no vomiting and no use of rescue medicines in patients with cancer receiving chemotherapy.
Skin-Related Side Effects From a Certain Cancer Treatment May Indicate Stronger Responses, Survival
January 28th 2022Side effects from cancer treatment with immunotherapy, which may include vitiligo and certain rashes, may point to who will respond better to the treatment, although more research is needed to determine how much weight to put on these data.
Cancer Survivors Share the Unexpected Side Effects Experienced During and After Treatment
January 11th 2022From mouth sores to cold sensitivities as well as a continued taste of chemicals, cancer survivors recently shared some of the more unexpected side effects they experienced during and after treatment.
What It Was Like to Take the Plunge And Get Acupuncture for Chemo-Induced Neuropathy
December 22nd 2021A patient with cancer writes about trying acupuncture as another potential tool to lessen the effects of chemo-induced peripheral neuropathy and offers advice for other patients on how to possibly deal with the debilitating side effect.
FDA Approves Orencia for GVHD Prevention After Hematopoietic Stem Cell Transplant
December 15th 2021The Food and Drug Administration approved Orencia, which is commonly used to treat conditions like rheumatoid arthritis, to prevent acute graft-versus-host-disease in adults and children who underwent a hematopoietic stem cell transplant from an unrelated donor.